- THE Big Data meeting for drug development budget holders
- Transforming theory into action, value and competitive advantage
- Capitalizing on the promise of real world evidence throughout the clinical development process
In 2015, this event will provide even more real-world examples of strategies improving decision-making during this most risky and expensive, but also potentially rewarding stage of the overall drug discovery, development and commercialization process.
Attendees will receive unique insights into where the major industry players are placing their bets to ensure Big Data in drug development provides a critical source of competitive advantage for years to come. They will also discover the right questions to ask of Big Data throughout the product lifecycle in order to build a more comprehensive body of real world evidence, and a better prediction of value.
Meet the senior leaders representing all of the functions that directly influence - and ultimately make- the decision of how individual pharma, CRO and biotech companies will harness the potential of Big Data to improve their clinical development strategies and results.